Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 292

1.

Fetal hypoxia and hyperglycemia in the formation of phenytoin-induced cleft lip and maxillary hypoplasia.

Ritchie HE, Oakes D, Farrell E, Ababneh D, Howe A.

Epilepsia Open. 2019 Jul 29;4(3):443-451. doi: 10.1002/epi4.12352. eCollection 2019 Sep.

2.

Ex vivo gene therapy using human bone marrow cells overexpressing BMP-2: "Next-day" gene therapy versus standard "two-step" approach.

Bougioukli S, Alluri R, Pannell W, Sugiyama O, Vega A, Tang A, Skorka T, Park SH, Oakes D, Lieberman JR.

Bone. 2019 Aug 6;128:115032. doi: 10.1016/j.bone.2019.08.005. [Epub ahead of print]

PMID:
31398502
3.

The Prospective Huntington At-Risk Observational Study (PHAROS): The Emotional Well-Being, Safety and Feasibility of Long-Term Research Participation.

Kayson E, Eberly S, Anderson KE, Marder K, Shoulson I, Oakes D, Young AB, Biglan K, Hersch S; Huntington Study Group PHAROS Investigators.

J Huntingtons Dis. 2019 Jul 29. doi: 10.3233/JHD-190365. [Epub ahead of print]

PMID:
31381523
4.

Calls to a Major Teratogen Information Service Regarding Exposures During Breastfeeding.

Hegedus E, Oakes DJ, Hill M, Ritchie HE, Kennedy DS.

Breastfeed Med. 2019 Aug 1. doi: 10.1089/bfm.2019.0010. [Epub ahead of print]

PMID:
31368784
5.

Phenotype-genotype discrepancies in the prospective Huntington at-risk observational study.

Shoulson I, Eberly S, Oakes D, Kayson E, Young AB; PHAROS Investigators.

Ann Clin Transl Neurol. 2019 May 1;6(6):1046-1052. doi: 10.1002/acn3.781. eCollection 2019 Jun.

6.

The choice not to undergo genetic testing for Huntington disease: Results from the PHAROS study.

Anderson KE, Eberly S, Marder KS, Oakes D, Kayson E, Young A, Shoulson I; PHAROS Investigators.

Clin Genet. 2019 Jul;96(1):28-34. doi: 10.1111/cge.13529. Epub 2019 May 15.

PMID:
31093973
7.

Overexpression of WNT16 Does Not Prevent Cortical Bone Loss Due to Glucocorticoid Treatment in Mice.

Alam I, Oakes DK, Reilly AM, Billingsley C, Sbeta S, Gerard-O'Riley RL, Acton D, Sato A, Bellido T, Econs MJ.

JBMR Plus. 2018 Oct 23;3(4):e10084. doi: 10.1002/jbm4.10084. eCollection 2019 Apr.

8.

Trends in computer navigation and robotic assistance for total knee arthroplasty in the United States: an analysis of patient and hospital factors.

Antonios JK, Korber S, Sivasundaram L, Mayfield C, Kang HP, Oakes DA, Heckmann ND.

Arthroplast Today. 2019 Mar 12;5(1):88-95. doi: 10.1016/j.artd.2019.01.002. eCollection 2019 Mar.

9.

Systematic Review and Meta-Analysis of Intrawound Vancomycin in Total Hip and Total Knee Arthroplasty: A Call for a Prospective Randomized Trial.

Heckmann ND, Mayfield CK, Culvern CN, Oakes DA, Lieberman JR, Della Valle CJ.

J Arthroplasty. 2019 Aug;34(8):1815-1822. doi: 10.1016/j.arth.2019.03.071. Epub 2019 Apr 1.

PMID:
31005433
10.

Complex Reconstruction of the Knee with a Free Vertical Rectus Abdominis Flap after Periprosthetic Soft Tissue Necrosis.

Perrault D, Manrique OJ, Lee G, Carre AL, Oakes DA, Wong AK.

Cureus. 2019 Jan 28;11(1):e3969. doi: 10.7759/cureus.3969.

11.

Long-term durability of Oakes salvage procedure to preserve Brescia-Cimino arteriovenous fistula.

Dua A, Rothenberg KA, Lavingia K, Oakes DD, Sorial E, Garcia-Toca M.

J Vasc Surg. 2019 Sep;70(3):853-857. doi: 10.1016/j.jvs.2018.12.034. Epub 2019 Mar 2.

PMID:
30837176
12.

Ambient and controlled exposures to particulate air pollution and acute changes in heart rate variability and repolarization.

Breitner S, Peters A, Zareba W, Hampel R, Oakes D, Wiltshire J, Frampton MW, Hopke PK, Cyrys J, Utell MJ, Kane C, Schneider A, Rich DQ.

Sci Rep. 2019 Feb 13;9(1):1946. doi: 10.1038/s41598-019-38531-9.

13.

Reply to "Studying reproducibility of data-driven Parkinson's disease subtypes".

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2018 Dec 28. pii: S1353-8020(18)30562-5. doi: 10.1016/j.parkreldis.2018.12.028. [Epub ahead of print] No abstract available.

PMID:
30655161
14.

Hyperglycemia in the Posttransplant Period: NODAT vs Posttransplant Diabetes Mellitus.

Gupta S, Pollack T, Fulkerson C, Schmidt K, Oakes DJ, Molitch ME, Wallia A.

J Endocr Soc. 2018 Oct 15;2(11):1314-1319. doi: 10.1210/js.2018-00227. eCollection 2018 Nov 1.

15.

A Review of Perioperative Analgesic Strategies in Cardiac Surgery.

Chanowski EJP, Ismawan JM, Oakes DA.

Int Anesthesiol Clin. 2018 Fall;56(4):e56-e83. doi: 10.1097/AIA.0000000000000200. Review. No abstract available.

PMID:
30204605
16.

Preface.

Oakes DA.

Int Anesthesiol Clin. 2018 Fall;56(4):1-2. doi: 10.1097/AIA.0000000000000207. No abstract available.

PMID:
30204601
17.

Using the Jigsaw Method to Teach Abdominal Anatomy.

Oakes DJ, Hegedus EM, Ollerenshaw SL, Drury H, Ritchie HE.

Anat Sci Educ. 2019 May;12(3):272-283. doi: 10.1002/ase.1802. Epub 2018 Sep 4.

PMID:
30179312
18.

Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators: The RAID Trial.

Zareba W, Daubert JP, Beck CA, Huang DT, Alexis JD, Brown MW, Pyykkonen K, McNitt S, Oakes D, Feng C, Aktas MK, Ayala-Parades F, Baranchuk A, Dubuc M, Haigney M, Mazur A, McPherson CA, Mitchell LB, Natale A, Piccini JP, Raitt M, Rashtian MY, Schuger C, Winters S, Worley SJ, Ziv O, Moss AJ; RAID Trial Investigators.

J Am Coll Cardiol. 2018 Aug 7;72(6):636-645. doi: 10.1016/j.jacc.2018.04.086.

19.

Reproducibility of data-driven Parkinson's disease subtypes for clinical research.

Mestre TA, Eberly S, Tanner C, Grimes D, Lang AE, Oakes D, Marras C.

Parkinsonism Relat Disord. 2018 Nov;56:102-106. doi: 10.1016/j.parkreldis.2018.07.009. Epub 2018 Jul 20.

PMID:
30056038
20.

Survival models and health sequences: discussion.

Oakes D.

Lifetime Data Anal. 2018 Oct;24(4):592-594. doi: 10.1007/s10985-018-9441-8. Epub 2018 Jul 11. No abstract available.

PMID:
29995260
21.

In vitro evaluation of a lentiviral two-step transcriptional amplification system using GAL4FF transactivator for gene therapy applications in bone repair.

Bougioukli S, Sugiyama O, Alluri RK, Yoho R, Oakes DA, Lieberman JR.

Gene Ther. 2018 Jul;25(4):260-268. doi: 10.1038/s41434-018-0024-9. Epub 2018 Jun 15.

PMID:
29907876
22.

Validation of data from electronic data warehouse in diabetic ketoacidosis: Caution is needed.

VanderWeele J, Pollack T, Oakes DJ, Smyrniotis C, Illuri V, Vellanki P, O'Leary K, Holl J, Aleppo G, Molitch ME, Wallia A.

J Diabetes Complications. 2018 Jul;32(7):650-654. doi: 10.1016/j.jdiacomp.2018.05.004. Epub 2018 May 8.

PMID:
29903409
23.

Selected health and lifestyle factors, cytosine-adenine-guanine status, and phenoconversion in Huntington's disease.

Tanner C, Marder K, Eberly S, Biglan K, Oakes D, Shoulson I; Huntington Study Group Prospective Huntington At-Risk Observational Study Investigators.

Mov Disord. 2018 Mar;33(3):472-478. doi: 10.1002/mds.27239. Epub 2018 Jan 3.

24.

Gene Therapy for Bone Repair Using Human Cells: Superior Osteogenic Potential of Bone Morphogenetic Protein 2-Transduced Mesenchymal Stem Cells Derived from Adipose Tissue Compared to Bone Marrow.

Bougioukli S, Sugiyama O, Pannell W, Ortega B, Tan MH, Tang AH, Yoho R, Oakes DA, Lieberman JR.

Hum Gene Ther. 2018 Apr;29(4):507-519. doi: 10.1089/hum.2017.097. Epub 2018 Mar 14.

25.

Early Gestational Hypoxia and Adverse Developmental Outcomes.

Ritchie HE, Oakes DJ, Kennedy D, Polson JW.

Birth Defects Res. 2017 Oct 16;109(17):1358-1376. doi: 10.1002/bdr2.1136. Review.

PMID:
29105381
26.

Cognition and the course of prodromal Parkinson's disease.

Weintraub D, Chahine LM, Hawkins KA, Siderowf A, Eberly S, Oakes D, Seibyl J, Stern MB, Marek K, Jennings D; PARS Investigators.

Mov Disord. 2017 Nov;32(11):1640-1645. doi: 10.1002/mds.27189. Epub 2017 Oct 24.

27.

The CREST-E study of creatine for Huntington disease: A randomized controlled trial.

Hersch SM, Schifitto G, Oakes D, Bredlau AL, Meyers CM, Nahin R, Rosas HD; Huntington Study Group CREST-E Investigators and Coordinators.

Neurology. 2017 Aug 8;89(6):594-601. doi: 10.1212/WNL.0000000000004209. Epub 2017 Jul 12.

28.

Safety of Converting From Tetrabenazine to Deutetrabenazine for the Treatment of Chorea.

Frank S, Stamler D, Kayson E, Claassen DO, Colcher A, Davis C, Duker A, Eberly S, Elmer L, Furr-Stimming E, Gudesblatt M, Hunter C, Jankovic J, Kostyk SK, Kumar R, Loy C, Mallonee W, Oakes D, Scott BL, Sung V, Goldstein J, Vaughan C, Testa CM; Huntington Study Group/Alternatives for Reducing Chorea in Huntington Disease Investigators.

JAMA Neurol. 2017 Aug 1;74(8):977-982. doi: 10.1001/jamaneurol.2017.1352. Erratum in: JAMA Neurol. 2018 Jan 1;75(1):133.

29.

Ambient and Controlled Particle Exposures as Triggers for Acute ECG Changes.

Rich DQ, Peters A, Schneider A, Zareba W, Breitner S, Oakes D, Wiltshire J, Kane C, Frampton MW, Hampel R, Hopke PK, Cyrys J, Utell MJ.

Res Rep Health Eff Inst. 2016 May;(186):5-75.

PMID:
28661614
30.

Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter-Deficit Prodromal Cohort.

Jennings D, Siderowf A, Stern M, Seibyl J, Eberly S, Oakes D, Marek K; PARS Investigators.

JAMA Neurol. 2017 Aug 1;74(8):933-940. doi: 10.1001/jamaneurol.2017.0985.

31.

A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III).

Biglan KM, Oakes D, Lang AE, Hauser RA, Hodgeman K, Greco B, Lowell J, Rockhill R, Shoulson I, Venuto C, Young D, Simuni T; Parkinson Study Group STEADY‐PD III Investigators.

Ann Clin Transl Neurol. 2017 May 9;4(6):360-368. doi: 10.1002/acn3.412. eCollection 2017 Jun.

32.

Disruptions in valine degradation affect seed development and germination in Arabidopsis.

Gipson AB, Morton KJ, Rhee RJ, Simo S, Clayton JA, Perrett ME, Binkley CG, Jensen EL, Oakes DL, Rouhier MF, Rouhier KA.

Plant J. 2017 Jun;90(6):1029-1039. doi: 10.1111/tpj.13538. Epub 2017 Apr 29.

33.

Counselling regarding paternal exposures: Can we do better?

Ritchie HE, Oakes DJ, Hegedus E, Hill M, Kennedy D.

Aust N Z J Obstet Gynaecol. 2017 Apr;57(2):162-167. doi: 10.1111/ajo.12584. Epub 2017 Mar 9.

PMID:
28276580
34.

Bone Mass and Strength are Significantly Improved in Mice Overexpressing Human WNT16 in Osteocytes.

Alam I, Reilly AM, Alkhouli M, Gerard-O'Riley RL, Kasipathi C, Oakes DK, Wright WB, Acton D, McQueen AK, Patel B, Lim KE, Robling AG, Econs MJ.

Calcif Tissue Int. 2017 Apr;100(4):361-373. doi: 10.1007/s00223-016-0225-4. Epub 2016 Dec 24.

35.

Glycemic Control Reduces Infections in Post-Liver Transplant Patients: Results of a Prospective, Randomized Study.

Wallia A, Schmidt K, Oakes DJ, Pollack T, Welsh N, Kling-Colson S, Gupta S, Fulkerson C, Aleppo G, Parikh N, Levitsky J, Norvell JP, Rademaker A, Molitch ME.

J Clin Endocrinol Metab. 2017 Feb 1;102(2):451-459. doi: 10.1210/jc.2016-3279.

36.

Phenotypic severity of autosomal dominant osteopetrosis type II (ADO2) mice on different genetic backgrounds recapitulates the features of human disease.

Alam I, McQueen AK, Acton D, Reilly AM, Gerard-O'Riley RL, Oakes DK, Kasipathi C, Huffer A, Wright WB, Econs MJ.

Bone. 2017 Jan;94:34-41. doi: 10.1016/j.bone.2016.10.016. Epub 2016 Oct 14.

PMID:
27746321
37.

Factors related to genetic testing in adults at risk for Huntington disease: the prospective Huntington at-risk observational study (PHAROS).

Quaid KA, Eberly SW, Kayson-Rubin E, Oakes D, Shoulson I; Huntington Study Group PHAROS Investigators and Coordinators.

Clin Genet. 2017 Jun;91(6):824-831. doi: 10.1111/cge.12893. Epub 2016 Nov 24.

38.

EVALUATION OF OUTCOMES AND COMPLICATIONS IN PATIENTS WHO EXPERIENCE HYPOGLYCEMIA AFTER CARDIAC SURGERY.

Lowden E, Schmidt K, Mulla I, Andrei AC, Cashy J, Oakes DJ, Aleppo G, Grady KL, Wallia A, Molitch ME.

Endocr Pract. 2017 Jan;23(1):46-55. doi: 10.4158/EP161427.OR. Epub 2016 Sep 28.

PMID:
27682356
39.

The use of (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) as a pathway-specific biomarker with AZD8186, a PI3Kβ/δ inhibitor.

Maynard J, Emmas SA, Blé FX, Barjat H, Lawrie E, Hancox U, Oakes D, Polanska UM, Barry ST.

EJNMMI Res. 2016 Dec;6(1):62. doi: 10.1186/s13550-016-0220-9. Epub 2016 Aug 11.

40.

Effect of Deutetrabenazine on Chorea Among Patients With Huntington Disease: A Randomized Clinical Trial.

Huntington Study Group, Frank S, Testa CM, Stamler D, Kayson E, Davis C, Edmondson MC, Kinel S, Leavitt B, Oakes D, O'Neill C, Vaughan C, Goldstein J, Herzog M, Snively V, Whaley J, Wong C, Suter G, Jankovic J, Jimenez-Shahed J, Hunter C, Claassen DO, Roman OC, Sung V, Smith J, Janicki S, Clouse R, Saint-Hilaire M, Hohler A, Turpin D, James RC, Rodriguez R, Rizer K, Anderson KE, Heller H, Carlson A, Criswell S, Racette BA, Revilla FJ, Nucifora F Jr, Margolis RL, Ong M, Mendis T, Mendis N, Singer C, Quesada M, Paulsen JS, Brashers-Krug T, Miller A, Kerr J, Dubinsky RM, Gray C, Factor SA, Sperin E, Molho E, Eglow M, Evans S, Kumar R, Reeves C, Samii A, Chouinard S, Beland M, Scott BL, Hickey PT, Esmail S, Fung WL, Gibbons C, Qi L, Colcher A, Hackmyer C, McGarry A, Klos K, Gudesblatt M, Fafard L, Graffitti L, Schneider DP, Dhall R, Wojcieszek JM, LaFaver K, Duker A, Neefus E, Wilson-Perez H, Shprecher D, Wall P, Blindauer KA, Wheeler L, Boyd JT, Houston E, Farbman ES, Agarwal P, Eberly SW, Watts A, Tariot PN, Feigin A, Evans S, Beck C, Orme C, Edicola J, Christopher E.

JAMA. 2016 Jul 5;316(1):40-50. doi: 10.1001/jama.2016.8655.

41.

The Cost of Getting Into Orthopedic Residency: Analysis of Applicant Demographics, Expenditures, and the Value of Away Rotations.

Camp CL, Sousa PL, Hanssen AD, Karam MD, Haidukewych GJ, Oakes DA, Turner NS.

J Surg Educ. 2016 Sep-Oct;73(5):886-91. doi: 10.1016/j.jsurg.2016.04.003. Epub 2016 May 12.

PMID:
27184179
42.

Does total antioxidant capacity modify adverse cardiac responses associated with ambient ultrafine, accumulation mode, and fine particles in patients undergoing cardiac rehabilitation?

Wang M, Utell MJ, Schneider A, Zareba W, Frampton MW, Oakes D, Hopke PK, Wiltshire J, Kane C, Peters A, Breitner S, Chalupa D, Rich DQ.

Environ Res. 2016 Aug;149:15-22. doi: 10.1016/j.envres.2016.04.031. Epub 2016 May 10.

43.

Orthopedic Surgery Applicants: What They Want in an Interview and How They Are Influenced by Post-Interview Contact.

Camp CL, Sousa PL, Hanssen AD, Karam MD, Haidukewych GJ, Oakes DA, Turner NS.

J Surg Educ. 2016 Jul-Aug;73(4):709-14. doi: 10.1016/j.jsurg.2016.03.009. Epub 2016 Apr 29.

PMID:
27137662
44.

INPATIENT HYPOGLYCEMIC EVENTS IN A COMPARATIVE EFFECTIVENESS TRIAL FOR GLYCEMIC CONTROL IN A HIGH-RISK POPULATION.

Welsh N, Derby T, Gupta S, Fulkerson C, Oakes DJ, Schmidt K, Parikh ND, Norvell JP, Levitsky J, Rademaker A, Molitch ME, Wallia A.

Endocr Pract. 2016 Sep;22(9):1040-7. doi: 10.4158/EP151166.OR. Epub 2016 Apr 28.

PMID:
27124695
45.

The Heart of the Matter: Increasing Quality and Charge Capture from Intraoperative Transesophageal Echocardiography.

Sanford JA, Kadry B, Oakes D, Macario A, Schmiesing C.

A A Case Rep. 2016 Apr 15;6(8):249-52. doi: 10.1213/XAA.0000000000000169.

PMID:
27082233
46.

Relationship Between Hyperglycemia and Heart Transplant Rejection.

Mateo R, Gupta S, Wallia A, Cameron C, Schmidt K, Oakes DJ, Aleppo G, Andrei AC, Wilcox JE, Grady K, Gordon R, Molitch ME.

Transplant Proc. 2015 Nov;47(9):2727-31. doi: 10.1016/j.transproceed.2015.09.063.

PMID:
26680082
47.

Early Clinical Predictors of Treatment-Resistant and Functional Outcomes in Parkinson's Disease.

Kurlan R, Ravina B, Eberly S, Lang AE, Tanner CM, Marek K, Marder K, Beck J, Elliott R, Oakes D, Shoulson I; PSG PostCEPT (LABS‐PD) Investigators.

Mov Disord Clin Pract. 2015 Dec 14;3(1):53-58. doi: 10.1002/mdc3.12273. eCollection 2016 Jan-Feb.

48.

Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials.

Huntington Study Group PHAROS Investigators, Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O'Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C.

JAMA Neurol. 2016 Jan;73(1):102-10. doi: 10.1001/jamaneurol.2015.2736.

PMID:
26569098
49.

Informativeness of Early Huntington Disease Signs about Gene Status.

Oster E, Eberly SW, Dorsey ER, Kayson-Rubin E, Oakes D, Shoulson I.

J Huntingtons Dis. 2015;4(3):271-7. doi: 10.3233/JHD-150156.

PMID:
26444024
50.

The Effect of Dofetilide on the Heart Rate of GD11 and GD13 Rat Embryos, in vivo, Using Ultrasound.

Ritchie H, Oakes D, Hung TT, Hegedus E, Sood S, Webster W.

Birth Defects Res B Dev Reprod Toxicol. 2015 Oct;104(5):196-203. doi: 10.1002/bdrb.21162. Epub 2015 Sep 24.

PMID:
26401846

Supplemental Content

Support Center